Abstract
Acute and prophylactic effects of carbamazepine are documented in a double-blind clinical trial in a 55-year-old treatment-refractory, lithium-nonresponsive, manic-depressive patient. Doubleblind crossover to two other anticonvulsants was also achieved; the patient showed no evidence of response to phenytoin or valproic acid. The clinical and theoretical issues raised by the selective response to carbamazepine in this patient are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 178-185 |
| Number of pages | 8 |
| Journal | Journal of Clinical Psychopharmacology |
| Volume | 4 |
| Issue number | 4 |
| State | Published - Aug 1984 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Selective response to the anticonvulsant carbamazepine in manic-depressive illness: A case study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver